Filing Details
- Accession Number:
- 0000899243-22-014117
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-04-06 16:59:58
- Reporting Period:
- 2022-04-04
- Accepted Time:
- 2022-04-06 16:59:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1334365 | Yuchun Lee | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-04-04 | 2,000 | $81.54 | 3,875 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-04-04 | 100 | $265.83 | 3,775 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-04-04 | 917 | $267.23 | 2,858 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-04-04 | 983 | $268.36 | 1,875 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-04-05 | 2,000 | $81.54 | 3,875 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-04-05 | 17 | $268.30 | 3,858 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-04-05 | 334 | $270.05 | 3,524 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-04-05 | 488 | $271.94 | 3,036 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-04-05 | 600 | $272.60 | 2,436 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-04-05 | 100 | $273.50 | 2,336 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-04-05 | 461 | $274.66 | 1,875 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2022-04-04 | 2,000 | $81.54 | 2,000 | $81.54 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2022-04-05 | 2,000 | $81.54 | 2,000 | $81.54 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 18,000 | 2023-05-31 | No | 4 | M | Direct | |
| 16,000 | 2023-05-31 | No | 4 | M | Direct |
Footnotes
- Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1.
- Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $267.23 (range $266.85 to $267.79).
- Open market sales reported on this line occurred at a weighted average price of $268.36 (range $267.97 to $268.81).
- Open market sales reported on this line occurred at a weighted average price of $270.05 (range $269.79 to $270.64).
- Open market sales reported on this line occurred at a weighted average price of $271.94 (range $271.35 to $272.27).
- Open market sales reported on this line occurred at a weighted average price of $272.60 (range $272.36 to $273.34).
- Open market sales reported on this line occurred at a weighted average price of $274.66 (range $274.63 to $274.68).
- Fully vested.
Billionaire Hedge Funds
